- Amanat S, Ghahri S, Dianatinasab A, Fararouei M, Dianatinasab M. Exercise and Type 2 Diabetes. Adv Exp Med Biol. 2020;1228:91-105. doi: 10.1007/978-981-15-1792-1_6. PubMed PMID: 32342452.
- Sampath Kumar A, Maiya AG, Shastry BA, Vaishali K, Ravishankar N, Hazari A, et al. Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis. Ann Phys Rehabil Med. 2019;62:98-103. doi: 10.1016/j.rehab.2018.11.001. PubMed PMID: 30553010.
- Sun Y, Ding S. NLRP3 Inflammasome in Diabetic Cardiomyopathy and Exercise Intervention. Int J Mol Sci. 2021;22. doi: 10.3390/ijms222413228. PubMed PMID: 34948026; PubMed Central PMCID: PMC8707657.
- Yu ZW, Zhang J, Li X, Wang Y, Fu YH, Gao XY. A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications. Life Sci. 2020;240:117138. doi: 10.1016/j.lfs.2019.117138. PubMed PMID: 31809715.
- Satheesan A, Kumar J, Leela KV, Murugesan R, Chaithanya V, Angelin M. Review on the role of nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome pathway in diabetes: mechanistic insights and therapeutic implications. Inflammopharmacology. 2024;32:2753-79. doi: 10.1007/s10787-024-01556-2. PubMed PMID: 39160391.
- Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19:477-89. doi: 10.1038/s41577-019-0165-0. PubMed PMID: 31036962; PubMed Central PMCID: PMC7807242.
- Luo B, Huang F, Liu Y, Liang Y, Wei Z, Ke H, et al. NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy. Front Physiol. 2017;8:519. doi: 10.3389/fphys.2017.00519. PubMed PMID: 28790925; PubMed Central PMCID: PMC5524816.
- Milan KL, Megha B, Ramkumar KM. Role of inflammasomes in diabetes mellitus: mechanisms, complications, and therapeutic potential. Mol Biol Rep. 2025;52:621. doi: 10.1007/s11033-025-10719-5. PubMed PMID: 40544214.
- Schroeder EC, Franke WD, Sharp RL, Lee DC. Comparative effectiveness of aerobic, resistance, and combined training on cardiovascular disease risk factors: A randomized controlled trial. PLoS One. 2019;14:e0210292. doi: 10.1371/journal.pone.0210292. PubMed PMID: 30615666; PubMed Central PMCID: PMC6322789.
- Chen X, Li H, Wang K, Liang X, Wang W, Hu X, et al. Aerobic Exercise Ameliorates Myocardial Inflammation, Fibrosis and Apoptosis in High-Fat-Diet Rats by Inhibiting P2X7 Purinergic Receptors. Front Physiol. 2019;10:1286. doi: 10.3389/fphys.2019.01286. PubMed PMID: 31681001; PubMed Central PMCID: PMC6798156.
- Mardare C, Kruger K, Liebisch G, Seimetz M, Couturier A, Ringseis R, et al. Endurance and Resistance Training Affect High Fat Diet-Induced Increase of Ceramides, Inflammasome Expression, and Systemic Inflammation in Mice. J Diabetes Res. 2016;2016:4536470. doi: 10.1155/2016/4536470. PubMed PMID: 26788518; PubMed Central PMCID: PMC4691630.
- Quiroga R, Nistal E, Estebanez B, Porras D, Juarez-Fernandez M, Martinez-Florez S, et al. Exercise training modulates the gut microbiota profile and impairs inflammatory signaling pathways in obese children. Exp Mol Med. 2020;52:1048-61. doi: 10.1038/s12276-020-0459-0. PubMed PMID: 32624568; PubMed Central PMCID: PMC8080668.
- Liang F, Huang T, Li B, Zhao Y, Zhang X, Xu B. High-intensity interval training and moderate-intensity continuous training alleviate beta-amyloid deposition by inhibiting NLRP3 inflammasome activation in APPswe/PS1dE9 mice. Neuroreport. 2020;31:425-32. doi: 10.1097/WNR.0000000000001429. PubMed PMID: 32150150.
- ZhuGe DL, Javaid HMA, Sahar NE, Zhao YZ, Huh JY. Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation. Arch Pharm Res. 2020;43:1311-24. doi: 10.1007/s12272-020-01295-2. PubMed PMID: 33245516.
- Guide for the Care and Use of Laboratory Animals. The National Academies Collection: Reports funded by National Institutes of Health. 8th ed. Washington (DC)2011. doi: 10.17226/12910. PubMed PMID: 21595115.
- Rashidpour A, Piralaiy E, Hamidian G, Ismael BR. Protective effects of aerobic exercise on cardiac histology and stereological parameters in a rat model of type 2 diabetes mellitus. J Diabetes Metab Disord. 2025;24:138. doi: 10.1007/s40200-025-01641-5. PubMed PMID: 40469910; PubMed Central PMCID: PMC12130402.
- Shaikh SA, Varatharajan R, Muthuraman A. Palm Oil Derived Tocotrienol-Rich Fraction Attenuates Vascular Dementia in Type 2 Diabetic Rats. Int J Mol Sci. 2022;23. doi: 10.3390/ijms232113531. PubMed PMID: 36362316; PubMed Central PMCID: PMC9653761.
- Parastesh M, Heidarianpour A, Sadegh M. Investigating the effects of endurance, resistance and combined training on reproductive hormones and sperm parameters of streptozotocin-nicotinamide diabetic male rats. J Diabetes Metab Disord. 2019;18:273-9. doi: 10.1007/s40200-018-0380-4. PubMed PMID: 31890651; PubMed Central PMCID: PMC6915199.
- Ghadiri N, Gorgin Karaji Z, Farsani ZH, Akbarzadeh H. The combined effects of resistance and endurance training with ursolic acid supplementation on some Alzheimer’s disease-related biomarkers in a rat model of type 2 diabetes. Bulletin of the National Research Centre. 2024;48:85. doi: 10.1186/s42269-024-01240-z.
- Galvan-Alvarez V, Martin-Rincon M, Gallego-Selles A, Martinez Canton M, HamedChaman N, Gelabert-Rebato M, et al. Determinants of the maximal functional reserve during repeated supramaximal exercise by humans: The roles of Nrf2/Keap1, antioxidant proteins, muscle phenotype and oxygenation. Redox Biol. 2023;66:102859. doi: 10.1016/j.redox.2023.102859. PubMed PMID: 37666117; PubMed Central PMCID: PMC10491831.
- Chen D, Sindone A, Huang MLH, Peter K, Jenkins AJ. Diabetic cardiomyopathy: insights into pathophysiology, diagnosis and clinical management. J Mol Cell Cardiol. 2025;206:55-69. doi: 10.1016/j.yjmcc.2025.06.013. PubMed PMID: 40623544.
- Rais N, Ved A, Ahmad R, Parveen K, Gautam GK, Bari DG, et al. Model of Streptozotocin-nicotinamide Induced Type 2 Diabetes: a Comparative Review. Curr Diabetes Rev. 2022;18:e171121198001. doi: 10.2174/1573399818666211117123358. PubMed PMID: 34789130.
- Stanford KI, Goodyear LJ. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ. 2014;38:308-14. doi: 10.1152/advan.00080.2014. PubMed PMID: 25434013; PubMed Central PMCID: PMC4315445.
- Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985). 2005;98:1154-62. doi: 10.1152/japplphysiol.00164.2004. PubMed PMID: 15772055.
- Zhang Y, Ye T, Zhou P, Li R, Liu Z, Xie J, et al. Exercise ameliorates insulin resistance and improves ASK1-mediated insulin signalling in obese rats. J Cell Mol Med. 2021;25:10930-8. doi: 10.1111/jcmm.16994. PubMed PMID: 34734480; PubMed Central PMCID: PMC8642671.
- Ding S, Xu S, Ma Y, Liu G, Jang H, Fang J. Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes. Biomolecules. 2019;9. doi: 10.3390/biom9120850. PubMed PMID: 31835423; PubMed Central PMCID: PMC6995523.
- Zhang X, Fu Y, Li H, Shen L, Chang Q, Pan L, et al. H3 relaxin inhibits the collagen synthesis via ROS- and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose. J Cell Mol Med. 2018;22:1816-25. doi: 10.1111/jcmm.13464. PubMed PMID: 29314607; PubMed Central PMCID: PMC5824385.
- Luo B, Li B, Wang W, Liu X, Liu X, Xia Y, et al. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model. Cardiovasc Drugs Ther. 2014;28:33-43. doi: 10.1007/s10557-013-6498-1. PubMed PMID: 24254031.
- Ye Y, Bajaj M, Yang HC, Perez-Polo JR, Birnbaum Y. SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor. Cardiovasc Drugs Ther. 2017;31:119-32. doi: 10.1007/s10557-017-6725-2. PubMed PMID: 28447181.
- Zhang H, Chen X, Zong B, Yuan H, Wang Z, Wei Y, et al. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation. J Cell Mol Med. 2018;22:4437-48. doi: 10.1111/jcmm.13743. PubMed PMID: 29993180; PubMed Central PMCID: PMC6111804.
- Zhang T, Ding S, Wang R. Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome. Int J Mol Sci. 2021;22. doi: 10.3390/ijms221910866. PubMed PMID: 34639204; PubMed Central PMCID: PMC8509472.
- Zaidi H, Byrkjeland R, Njerve IU, Akra S, Solheim S, Arnesen H, et al. Effects of exercise training on inflammasome-related mediators and their associations to glucometabolic variables in patients with combined coronary artery disease and type 2 diabetes mellitus: Sub-study of a randomized control trial. Diab Vasc Dis Res. 2019;16:360-8. doi: 10.1177/1479164119836922. PubMed PMID: 30939905.
- Lee J, Lee Y, LaVoy EC, Umetani M, Hong J, Park Y. Physical activity protects NLRP3 inflammasome-associated coronary vascular dysfunction in obese mice. Physiol Rep. 2018;6:e13738. doi: 10.14814/phy2.13738. PubMed PMID: 29932503; PubMed Central PMCID: PMC6014451.
- Hong J, Park E, Lee J, Lee Y, Rooney BV, Park Y. Exercise training mitigates ER stress and UCP2 deficiency-associated coronary vascular dysfunction in atherosclerosis. Sci Rep. 2021;11:15449. doi: 10.1038/s41598-021-94944-5. PubMed PMID: 34326395; PubMed Central PMCID: PMC8322067.
- Ma M, Chen W, Hua Y, Jia H, Song Y, Wang Y. Aerobic exercise ameliorates cardiac hypertrophy by regulating mitochondrial quality control and endoplasmic reticulum stress through M(2) AChR. J Cell Physiol. 2021;236:6581-96. doi: 10.1002/jcp.30342. PubMed PMID: 33615478.
|